Fri, September 23, 2011
Thu, September 22, 2011
Wed, September 21, 2011
Tue, September 20, 2011
Mon, September 19, 2011
Sun, September 18, 2011
Sat, September 17, 2011
Fri, September 16, 2011
Thu, September 15, 2011
Wed, September 14, 2011
Tue, September 13, 2011
Mon, September 12, 2011
Sun, September 11, 2011
Sat, September 10, 2011
Fri, September 9, 2011
Thu, September 8, 2011
Wed, September 7, 2011
Tue, September 6, 2011
Mon, September 5, 2011
Sun, September 4, 2011
Sat, September 3, 2011
Fri, September 2, 2011
Thu, September 1, 2011
Wed, August 31, 2011
Tue, August 30, 2011
[ Tue, Aug 30th 2011 ] - Market Wire
00 a.m. ET
Mon, August 29, 2011
Fri, August 26, 2011
Thu, August 25, 2011

SurModics to Attend CL Kinga?s 9th Annual Best Ideas Conference on September 14


//health-fitness.news-articles.net/content/2011/ .. nnual-best-ideas-conference-on-september-14.html
Published in Health and Fitness on Monday, September 12th 2011 at 8:22 GMT by Market Wire   Print publication without navigation


EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will participate in CL Kinga™s 9th Annual Best Ideas Conference in New York City on Wednesday, September 14, 2011. Gary Maharaj, SurModicsa™ President and Chief Executive Officer, and Timothy Arens, Vice President of Finance and interim Chief Financial Officer, will discuss the Companya™s strategy and business conditions during a formal presentation beginning at 2:15 pm EDT.

The presentation will be available via webcast by visiting the investor relations portion of the Company's website at [ www.surmodics.com ] on the day of the Conference and clicking the webcast icon. In addition, the Conference audio and slide presentation will be archived on the Company's website following the meeting.

About SurModics, Inc.

SurModicsa™ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the worlda™s foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModicsa™ website is not part of this release or part of any filings the Company makes with the SEC.


Publication Contributing Sources